Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Diabetes Reviews
  4. Volume 20, Issue 3
  5. Article
Volume 20, Issue 3
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

This narrative review aimed to discuss the potential interplay among frailty syndrome, sarcopenia and metformin in type 2 diabetes mellitus (T2DM). There is emerging evidence on the potential protective role of metformin on both frailty and sarcopenia. However, results are not always consistent. Thus, further research is needed to provide a definitive answer on any role of metformin in improving frailty and/or sarcopenia in T2DM.

© Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cdr/10.2174/1573399820666230727101141
2024-03-01
2024-12-29

  • From This Site

    /content/journals/cdr/10.2174/1573399820666230727101141
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/content/journals/cdr/10.2174/1573399820666230727101141
Loading

  • Article Type:     Research Article
Keyword(s): antidiabetic drugs; frailty; low muscle mass; Metformin; sarcopenia; T2DM

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test